This service supports EIC Pathfinder and EIC Transition beneficiaries from the biotech, pharma and healthtech sectors related to innovations to fight antimicrobial resistance (AMR) with R&D and business development advice and coaching sessions. This service aims to accelerate the efficiency of technology maturation, increase the visibility/exposure, and help companies to reach an investible stage. Advice will be delivered in all feasible ways, e.g. via e-mail exchange, via 1-1 calls or in personal meetings. INCATE experts will analyse strengths and weaknesses of the individual concept or technology and make the teams aware of potential translational hurdles which are foreseeable. This includes development of competitive Target Product Profiles and related development paths, IP conflicts, regulatory issues, technical challenges or conceptual constraints. EIC beneficiaries will also have the opportunity to get feedback from Pharma companies and industry experts. The duration of the service can vary and depends on the beneficiary’s needs. Hybrid implementation (mainly online).
This service is restricted to innovative concepts in the field of antimicrobial resistance (AMR) and to TRL 1-4.
Free of charge